Profilo
Temre Johnson is currently the Head-Investor Relations & Media Contact at Alpine Immune Sciences, Inc. Prior to this role, Mr. Johnson worked as the Director-Investor Relations & Communications at Mirati Therapeutics, Inc. from 2018 to 2022.
Posizioni attive di Temre Johnson
| Società | Posizione | Inizio |
|---|---|---|
| ALPINE IMMUNE SCIENCES, INC. | Investor Relations Contact | - |
Precedenti posizioni note di Temre Johnson
| Società | Posizione | Fine |
|---|---|---|
| MIRATI THERAPEUTICS | Investor Relations Contact | 01/06/2022 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ALPINE IMMUNE SCIENCES, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. BiotechnologyHealth Technology Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA. | Health Technology |
- Borsa valori
- Insiders
- Temre Johnson
